Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia

This publication has 47 references indexed in Scilit:

• Gamma Oscillatory Power is Impaired During Cognitive Control Independent of Medication Status in First-Episode Schizophrenia
  Neuropsychopharmacology, 2010
• Neurophysiological and Computational Principles of Cortical Rhythms in Cognition
  Physiological Reviews, 2010
• Gamma Oscillation Deficits and the Onset and Early Progression of Schizophrenia
  Harvard Review of Psychiatry, 2010
• Role of Basal Ganglia in Sleep–Wake Regulation: Neural Circuitry and Clinical Significance
  Frontiers in Neuroanatomy, 2010
• Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia
  Behavioural Brain Research, 2009
• NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness
  PLOS ONE, 2009
• NMDA receptor-dependent switching between different gamma rhythm-generating microcircuits in entorhinal cortex
  Proceedings of the National Academy of Sciences, 2008
• γ-Band Auditory Steady-State Responses Are Impaired in First Episode Psychosis
  Biological Psychiatry, 2008
• Region-Specific Changes in Gamma and Beta2 Rhythms in NMDA Receptor Dysfunction Models of Schizophrenia
  Schizophrenia Bulletin, 2008
• A Neurobehavioral Systems Analysis of Adult Rats Exposed to Methylazoxymethanol Acetate on E17: Implications for the Neuropathology of Schizophrenia
  Biological Psychiatry, 2006